Abstract:The plasminogen activator staphylokinase(Sak) is a promising thrombolytic agent for treatment of blood-clotting disorders, but it is immunogenic in man. Many efforts have been undertaken to reduce the immunogenicity of Sak by protein engineering. Some variants have been obtained with reduction of the immunoreactivity and immunogenicity. However, we find that lyophilized Sak, investigated by SDS-PAGE, HPLC, zymography and Western blot analysis, has apperant tendency to polymerize, which may increase its immunogenicity. hi an effort to disrupt dimmer formation of Sak, without loss of its plasminogen activator activity, the binding interface of the dimer was predicted by protein docking based on the crystal structure of Sak. Hydrophobie regions were found to be mainly responsible for the binding interface. Therefore, four plasmids encoding Sak mutants were constructed and expressed in E. Coli. The expression products were purified and characterized in vitro and in vivo. One of these variants of Sak, RGDSak, possessed much lower tendency to polymerize and lower immunogenicity than wide-type Sak(wt-Sak), as shown by SDS-PAGE after incubated with normal saline at room tempature for 24 h and in the guinea pigs immunized by RGD-Sak, using wt-Sak as control. RGD-Sak was comparable with wt-Sak in its ability to form complex with human plasmin(hPlm), the catalytic efficiency of the preformed Sak-hPlm complex (0.11 |jM-' s-', 0.16 |iM"' s-', respectively) or its ability to activate human plasminogen(hPlg) by catalytic amounts. Moreover, platelet aggregation induced by ADP (20 nM) was significantly inhibited by RGDSak (2 (iM), due to the favourable three dimentional structure, with the Arg-Gly-Asp sequence exposed outside. The subtle mechanism of the polymer formation is currently being investigated by the crystal structure of Sak dimer.

Purification and Characterization of a Staphylokinase Variant, K35R

Separation and Purification of Nattokinase Produced by Bacillus Subtilis with Ammonium Sulfate Precipitation and Chromatography

[The Renaturation and Purification of RGD-staphylokinase by Gel Filtration].

Preparation and Characterization of PLGA Microspheres Containing a Staphylokinase Variant (K35R).

Construction and Characterization of Novel Staphylokinase Variants with Antiplatelet Aggregation Activity and Reduced Immunogenecity.

Monitoring Host Cell Protein Contaminant Clearance During Purification of a Recombinant Staphylokinase Variant K35R by Immunological Assay

Stabilization and Encapsulation of a Staphylokinase Variant (K35R) into Poly(lactic-Co-glycolic Acid) Microspheres.

ARG-GLY-ASP(RGD)-containing variant of recombinant staphylokinase that possesses lower tendency to polymerize and inhibits platelet aggregation

Refolding of a Staphylokinase Variant Y1-Sak by Reverse Dilution.

Molecular Design, Cloning, Expression and Purification of NH(2)-terminal Mutant of Staphylokinase Deltansak

Separation of Recombinant Geranylgeranyl Diphosphate Synthase of Deinococcus Radiodurans from Expressed Strain Cell Homogenate by Immobilized Metal Affinity Chromatography on a Characterized Monolithic Cryogel Column

Purification and Characterization of a Cis-Epoxysuccinic Acid Hydrolase from Bordetella Sp. Strain 1–3

[Purification and Characteristics of Creatininase from Arthrobacter Sp].

Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities

Crystallization and Preliminary X-Ray Crystallographic Studies of Staphylokinase Variant S41g

Crystal structure of a staphylokinase: variant a model for reduced antigenicity.

Functional Properties of a Novel Mutant of Staphylokinase with Platelet-Targeted Fibrinolysis and Antiplatelet Aggregation Activities

Expression,purification and Identification of Kringle Domain Deletion Mutant of Human Plasminogen in Pichia Pastoris

Purification, characterization, and crystallization of the adhesive domain of SdrD from Staphylococcus aureus.

Purification and Characterization of a Small Thermostable Protease from Streptomyces sp. CNXK100

Studies on the pilot of recombinant streptokinase